Title : The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease - Jones_2012_J.Pharmacol.Exp.Ther_340_404 |
Author(s) :
Jones CK , Bubser M , Thompson AD , Dickerson JW , Turle-Lorenzo N , Amalric M , Blobaum AL , Bridges TM , Morrison RD , Jadhav S , Engers DW , Italiano K , Bode J , Daniels JS , Lindsley CW , Hopkins CR , Conn PJ , Niswender CM |
Ref :
Journal of Pharmacology & Experimental Therapeutics , 340 :404 , 2012 |
Abstract : Jones_2012_J.Pharmacol.Exp.Ther_340_404 |
ESTHER : Jones_2012_J.Pharmacol.Exp.Ther_340_404 |
PubMedSearch : Jones_2012_J.Pharmacol.Exp.Ther_340_404 |
PubMedID: 22088953 |